The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

Sambucol Black Elderberry Immune Defence Lozenge (180535)

ARTG ID 180535

ARTG Name

Sambucol Black Elderberry Immune Defence Lozenge

Product name

Sambucol Black Elderberry Immune Defence Lozenge

ARTG Date

2 March 2011

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

ascorbic acid

Honey

Sambucus nigra

zinc gluconate

Licence category

LI

Licence status

A

Summary

Sambucol Black Elderberry Immune Defence Lozenge (Pharmacare Laboratories Pty Ltd)

28 September 2022

Listed medicine compliance report

Medicine continues to be permitted for supply (View full entry for advice on the safety of using this medicine.)